SEPTEMBER 2011 | Incorporates published evidence to February 2011
A CLINICAL PRACTICE GUIDELINE DEVELOPED BY NATIONAL BREAST AND OVARIAN CANCER CENTRE (NBOCC)*
This document supplements the guideline recommendation on management of the axilla contained in the National Breast Cancer Centre* Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001 (chapter 4.4, pages 55–59, including recommendation 9).1
This guideline is complemented by the NBOCC Recommendations for use of sentinel node biopsy in early (operable) breast cancer, 2008.2
ISBN Online: 978-1-74127-119-5
©Cancer Australia 2011
This guideline includes statements and recommendations based on available high-level evidence about axillary staging and management in women with early (operable) breast cancer. The guideline aims to provide health professionals with information to assist in making management recommendations for improved patient outcomes. NBOCC also develops information specifically for consumers and general practitioners about early (operable) breast cancer diagnosis and treatment options, including management of the axilla.
*In February 2008, National Breast Cancer Centre (NBCC), incorporating the Ovarian Cancer Program, changed its name to National Breast and Ovarian Cancer Centre (NBOCC). In July 2011, NBOCC amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.